HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Africa Health Research Institute (AHRI), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
J Virol. 2018 Jul 17;92(15). doi: 10.1128/JVI.00659-18. Print 2018 Aug 1.
Despite decades of focused research, the field has yet to develop a prophylactic vaccine for HIV-1 infection. In the RV144 vaccine trial, nonneutralizing antibody responses were identified as a correlate for prevention of HIV acquisition. However, factors that predict the development of such antibodies are not fully elucidated. We sought to define the contribution of circulating T follicular helper (cTfh) subsets to the development of nonneutralizing antibodies in HIV-1 clade C infection. Study participants were recruited from an acute HIV-1 clade C infection cohort. Plasma anti-gp41, -gp120, -p24, and -p17 antibodies were screened using a customized multivariate Luminex assay. Phenotypic and functional characterizations of cTfh cells were performed using HLA class II tetramers and intracellular cytokine staining. In this study, we found that acute HIV-1 clade C infection skewed the differentiation of functional cTfh subsets toward increased Tfh1 ( = 0.02) and Tfh2 ( < 0.0001) subsets, with a concomitant decrease in overall Tfh1-17 (which shares both Tfh1 and Tfh17 properties) ( = 0.01) and Tfh17 ( < 0.0001) subsets, compared to the subsets found in HIV-negative subjects. Interestingly, the frequencies of Tfh1 cells during acute infection (5.0 to 8.0 weeks postinfection) correlated negatively with the set point viral load ( = 0.03, Spearman rho [] = -60) and were predictive of p24-specific plasma IgG titers at 1 year of infection ( = 0.003, = 0.85). Taken together, our results suggest that the circulating Tfh1 subset plays an important role in the development of anti-HIV antibody responses and contributes to HIV suppression during acute HIV-1 infection. These results have implications for vaccine studies aimed at inducing long-lasting anti-HIV antibody responses. The HIV epidemic in southern Africa accounts for almost half of the global HIV burden, with HIV-1 clade C being the predominant strain. It is therefore important to define immune correlates of clade C HIV control that might have implications for vaccine design in this region. T follicular helper (Tfh) cells are critical for the development of HIV-specific antibody responses and could play a role in viral control. Here we showed that the early induction of circulating Tfh1 cells during acute infection correlated positively with the magnitude of p24-specific IgG and was associated with a lower set point viral load. This study highlights a key Tfh cell subset that could limit HIV replication by enhancing antibody generation. This study underscores the importance of circulating Tfh cells in promoting nonneutralizing antibodies during HIV-1 infection.
尽管经过几十年的集中研究,该领域尚未开发出预防 HIV-1 感染的预防性疫苗。在 RV144 疫苗试验中,非中和抗体反应被确定为预防 HIV 获得的相关因素。然而,预测这种抗体发展的因素尚未完全阐明。我们试图确定循环滤泡辅助性 T 细胞(cTfh)亚群对 HIV-1 组 C 感染中非中和抗体发展的贡献。研究参与者从急性 HIV-1 组 C 感染队列中招募。使用定制的多变量 Luminex 测定法筛选血浆抗 gp41、-gp120、-p24 和 -p17 抗体。使用 HLA 类 II 四聚体和细胞内细胞因子染色对 cTfh 细胞进行表型和功能表征。在这项研究中,我们发现急性 HIV-1 组 C 感染使功能性 cTfh 亚群向增加的 Tfh1(= 0.02)和 Tfh2(<0.0001)亚群分化,同时总 Tfh1-17(具有 Tfh1 和 Tfh17 特性)(= 0.01)和 Tfh17(<0.0001)亚群减少,与 HIV 阴性受试者中的亚群相比。有趣的是,急性感染期间 Tfh1 细胞的频率(感染后 5.0 至 8.0 周)与设定点病毒载量呈负相关(= 0.03,Spearman rho []=-60),并预测感染 1 年时 p24 特异性血浆 IgG 滴度(= 0.003,= 0.85)。总之,我们的结果表明,循环 Tfh1 亚群在抗 HIV 抗体反应的发展中起重要作用,并有助于急性 HIV-1 感染期间的 HIV 抑制。这些结果对旨在诱导长效抗 HIV 抗体反应的疫苗研究具有重要意义。南部非洲的 HIV 流行占全球 HIV 负担的近一半,HIV-1 组 C 是主要毒株。因此,确定与组 C HIV 控制相关的免疫相关性因素对于该地区的疫苗设计非常重要。滤泡辅助性 T 细胞(Tfh)细胞是 HIV 特异性抗体反应发展的关键,可能在病毒控制中发挥作用。在这里,我们表明急性感染期间循环 Tfh1 细胞的早期诱导与 p24 特异性 IgG 的幅度呈正相关,并与较低的设定点病毒载量相关。这项研究强调了一个关键的 Tfh 细胞亚群,通过增强抗体产生,可能限制 HIV 复制。这项研究强调了循环 Tfh 细胞在 HIV-1 感染期间促进非中和抗体的重要性。